FDA weighs e-inserts or paperless labeling

The FDA is weighing whether to allow a system for electronic insert information for most prescription drugs, replacing paper Rx inserts.

Is it time to make prescribing information electronic and forgo paper package inserts for most prescription drugs? Manufacturers have long led an effort to move toward "paperless labeling," which they say could save millions of dollars. Now the Food & Drug Administration is exploring the idea with a call for comments and a recent hearing at its Rockville, Md., offices.

View Full Article

Author(s): 

Kathryn Foxhall

Journal: 

Drug Topics, Jun 4, 2007

Copyright: 

© Advanstar Communications. All rights reserved.